The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Oral Solid Dosage Contract Manufacturing Market During The Forecast Period?
The oral solid dosage contract manufacturing market has demonstrated substantial expansion in recent years. This market is set to increase from $42.39 billion in 2025 to $45.59 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.6%. Historically, this growth can be attributed to several factors including rising pressure to reduce in-house manufacturing costs, increasing complexity of oral solid dosage formulations, growing generic drug production volumes, limited internal manufacturing capacity of pharma companies, and increasing reliance on third-party CMOs.
The oral solid dosage contract manufacturing market is projected for significant expansion over the coming years, with its size expected to reach $59.05 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.7%. This growth trajectory is fueled by several factors, including the escalating demand for scalable pharmaceutical manufacturing solutions, a growing pipeline of oral solid dosage drugs, increased investment in advanced manufacturing technologies, the expansion of pharmaceutical outsourcing into emerging markets, and a heightened need for flexible and rapid production capabilities. Concurrently, major trends for the forecast period encompass pharmaceutical companies increasingly outsourcing oral solid dosage manufacturing, a greater demand for high-volume and cost-efficient tablet and capsule production, wider adoption of modified and controlled-release oral solid dosage forms, an elevated focus on regulatory compliance and quality assurance in contract manufacturing, and a rising preference for comprehensive end-to-end manufacturing and packaging services.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp
Which Important Drivers Are Guiding The Oral Solid Dosage Contract Manufacturing Market Growth?
The oral solid dosage contract manufacturing market is anticipated to expand due to the escalating demand for generic drugs. Generic drugs are pharmaceutical products that exhibit bioequivalence to their brand-name counterparts concerning dosage, strength, safety, performance, quality, and intended application. This rising demand for generic medications is driven by patent expirations, ongoing cost containment initiatives, regulatory incentives, and broader access to healthcare services. Oral solid dosage contract manufacturing plays a vital role in supporting the production and distribution of generic drugs by allowing contract manufacturers to boost their operational efficiency, decrease costs, guarantee high-quality manufacturing, and facilitate a quicker and more effective market entry for these products. For example, in 2025, the Food and Drug Administration, a US-based federal agency, reported that over 35,000 generic drugs had been approved by the FDA, with 9 out of 10 prescriptions being filled with generic drugs. Additionally, in November of 2024, the FDA issued more than 800 revised Product-Specific Guidances (PSGs) for immediate-release solid oral generic drug products. Thus, the growing demand for generic drugs is a significant force driving the growth of the oral solid dosage contract manufacturing market.
What Are The Key Segment Divisions In The Oral Solid Dosage Contract Manufacturing Market Segment Structure?
The oral solid dosage contract manufacturing market covered in this report is segmented –
1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
4) By End User: Large Size Companies, Medium And Small Size Companies
Subsegments:
1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules
3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders
4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules
5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules
What Trends Are Influencing The Evolution Of The Oral Solid Dosage Contract Manufacturing Market?
Leading companies in the oral solid dosage contract manufacturing market are concentrating on developing inventive solutions, such as continuous manufacturing lines, to uphold their market presence. A continuous manufacturing line describes a production setup or system that employs continuous manufacturing processes for the creation of pharmaceuticals or other goods. For example, in January 2023, WuXi STA, a pharmaceutical company from China, introduced its inaugural continuous manufacturing line for oral solid pharmaceutical products. This innovative facility signifies a major stride in pharmaceutical production, harnessing continuous manufacturing principles to improve efficiency, quality, and adaptability in drug manufacturing processes. This flexibility optimizes production schedules and decreases downtime, thereby accelerating the delivery of crucial medications to patients.
Which Organizations Are Engaged In The Oral Solid Dosage Contract Manufacturing Market?
Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma
Get The Full Oral Solid Dosage Contract Manufacturing Market Report:
Which Region Accounts For The Largest Portion Of The Oral Solid Dosage Contract Manufacturing Market?
Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Oral Solid Dosage Contract Manufacturing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2026, By The Business Research Company
Oral Care Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report
Dental Flap Surgery Market Report
https://www.thebusinessresearchcompany.com/report/dental-flap-surgery-global-market-report
Mouthwash Market Report
https://www.thebusinessresearchcompany.com/report/mouthwash-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model